In VitroEvaluation of Anticancer Activity for Novel Family of Synthetic Copper/Polyamines Complexes

Year: 
2015
Discussion Committee: 
Dr. Ashraf Sawafta / Supervisor
Dr. Ismail Warrad / Co-Supervisor
Dr. Hilal Zaid / External Examiner
Dr. Mohammed Al-Nuri / Internal Examiner
Supervisors: 
Dr. Ashraf Sawafta / Supervisor
Dr. Ismail Warrad / Co-Supervisor
Authors: 
Bayan Mustafa Mohammad Mansour
Abstract: 
The cancer mortality and morbidity rate is rising all over the world in developed countries and in developing ones which make cancera major health problem. Many researches and efforts have been made in order to cure cancer, stop its spread or even to contain its damage. Chemotherapy is widely used to treat cancer but its side effects and toxicity are a major concern. One of the most significant discoveries in cancer chemotherapy is cisplatin which is very effective in treating different types of cancer especially testicular cancer which has a cure rate exceeds 90%. However, the treatment is limited because of several side effectsin addition to inherit and acquired resistance that limits its usage too. These drawbacks have motivated extensive search for other active antitumor metal- based complexes with improved pharmacological properties. This study investigates the anticancer activity of copper polyamines complexes. Seven complexes were prepared and screened in vitro for both cytotoxic and cytostatic activities against four cell lines (human muscle cells as normal control: L6 cell line, colon cancer: Hct cell line, prostate cancer: PC3 cell line and liver cancer: HepG2 cell line) using MTT test. Results shows that complex 1 and complex 3 induced cytotoxic effect on Hct (IC50: 0.03, 0.015), PC3 (IC50: 0.02, 0.015) and HepG2 (IC50: 0.015, 0.015) cell lines at nontoxic level compared to its effect on L6 cell line (IC50: 0.07). Also complex 7 induced cytotoxic effect on HepG2 cell line (IC50: 0.07) at nontoxic level compared to its effect on L6 cell line (IC50: 0.09). However, for cytostatic effect complex 1 and complex 3 induced cytostatic effect on PC3 and HepG2 (IC50: 0.015) cell lines at nontoxic level compared to its effect on L6 cell line (IC50: 0.02), also complex 4 and complex 5 induced cytostatic effect on HepG2 cell line (IC50: 0.13, 0.09) at nontoxic level compared to its effect on L6 cell line (IC50: 0.18, 0.1). These complexes exhibited promising antiproliferative activity against tested cell lines which indicates that these complexes have anticancer effect at nontoxic concentrations.
Pages Count: 
48
Status: 
Published